Cellular Effects in Experimental Models Across experimental models, BPC-157 exposure is associated with several measurable cellular responses
Research FAQ (laboratory use only) What is SLU-PP-332
Individuals who have undergone weight loss surgeries, as these procedures can affect B12 absorption
Health Canada has not approved BPC-157 for any indication, and the August 2025 Canada Peptide advisory listed BPC-157 among seized unauthorized injectable peptide drugs
07 Refrigerate Store reconstituted BPC-157 at refrigerator temperature (35.6-46.4F / 2-8C)
Their compounding status under federal law is still being determined: removal from the Category 2 restricted list takes effect April 23, 2026, and the FDAs Pharmacy Compounding Advisory Committee will review whether to officially clear any of them at its July 23-24, 2026 meeting